Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development
company, today announced it has received formal notification for the issuance
of four patents in Mexico for its broad IP platform encompassing "Filtering
Devices Incorporating Nanoparticles." The patent coverage will include
three main methods of associating nanoparticles with filter media: (1) having
pellets of nanoparticles located adjacent to the filter media, (2) coating the
filter media with a powder of nanoparticles, and (3) impregnating the nanoparticles
into the filter media.
The Company already holds this broad patented protection in Australia, India,
New Zealand, Russia, Singapore and Taiwan and has active applications encompassing
40+ countries around the world including the United States. "This expansion
of protected intellectual property continues to increase the value of our overall
portfolio and should build shareholder value. The strategic advantage of this
specific coverage as it relates to potential licensee partnerships and nanotechnology
enhanced filtration product manufacturing is quite promising," said Thomas
K. Allen, President and CEO, ANI.
In addition, ANI continues to focus on U.S. patent efforts tied to its NanoFense(TM)
formulation, a proprietary antimicrobial nanoparticle filter "coating."
This technology development effort complements and bolsters all of the issued
patent coverage for many air filtration applications in some of the most heavily
populated regions of the world. "Our focused two-prong approach to building
a valuable and synergistic IP portfolio will directly benefit potential licensees
in all air filtration applications," stated Mr. Allen.
ANI is a marketer and developer of innovative nanotechnology-based air filtration
products specifically targeted to eradicate bacteria, virus and fungi and is
the owner of NEFT(TM) (Nanoparticle - Enhanced - Filtration - Technology), a
broad platform with significant application potential in consumer and industrial
market segments geared to reducing the transmission of infectious pathogens.